🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study aims to evaluate the efficacy brentuximab vedotin as consolidati...
Status
Completed
Location
CH Victor Dupouy
Start Date
2015-04
Trial ID
NCT02298283
RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Status
Completed
Location
Krankenanstalten Gilead gCmbH Neurochirurgische Klinik
Start Date
2010-10
Trial ID
NCT01228331
About 60% of patients with DLBCL can be cured with a chemotherapy program. ...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2008-07-01
Trial ID
NCT00712582
Standard treatment for stage III Non-Small Cells Lung Cancer (NSCLC) not el...
Status
Terminated
Location
Gustave Roussy Institute
Start Date
2021-09-24
Trial ID
NCT04765709
This study hypothesizes that approximately 50% of rectal cancer patients ca...
Status
Recruiting
Location
Nacional Cancer Institute
Start Date
2025-01-06
Trial ID
NCT06758830
The purpose of this study is to determine whether JNJ-90301900 added to con...
Status
Recruiting
Location
Moores Cancer Center at UC San Diego Health
Start Date
2024-12-06
Trial ID
NCT06667908
The purpose of this study is to assess the efficacy and safety of INCMGA000...
Status
Withdrawn
Location
Multiple Locations
Start Date
2020-07-31
Trial ID
NCT04203511
Treatments Being Tested
This study is designed for participants who have cancer of the upper gastro...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-05-19
Trial ID
NCT04931420
RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Status
Completed
Location
Universitaetsklinikum Giessen-Marburg
Start Date
2007-01
Trial ID
NCT00433459
Nivolumab (BMS-936558) is a fully human, IgG4 (kappa) isotype mAb that bind...
Status
Active Not Recruiting
Location
Guangdong Lung Cancer Institute, Guangdong General Hospital, Guangdong Academy of Medical Sciences
Start Date
2019-08-08
Trial ID
NCT04015778